Maryland drug company cuts COO role, to lay off 400

Emergent BioSolutions, a Gaithersburg, Md.-based company that makes multiple vaccines and achieved the first FDA approval for an over-the-counter naloxone nasal spray, plans to reduce operations at three facilities, lay off about 400 workers and cut its COO role. 

Advertisement

In an Aug. 8 news release, the company said it will shrink operations in Baltimore; Rockville, Md.; and Canton, Mass. Before Oct. 7, the Baltimore location will lay off 211 employees and Rockville will lay off 20, according to WARN notices. Massachusetts has not updated its WARN notices dashboard since Aug. 4.

Adam Havey, an executive vice president and COO, is exiting Sept. 30, Emergent said in the release. The biotech said the changes will result in savings of more than $100 million, according to an Aug. 8 news release.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.